[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100637351":3},{"organization":4,"armGroups":7,"interventions":29,"overallOfficials":34,"centralContacts":34,"locations":34,"responsibleParty":44,"collaborators":34,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":34,"eligibilityCriteria":53,"healthyVolunteers":50,"sex":54,"minAge":34,"maxAge":55,"enrollmentInfo":56,"targetDuration":34,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":66,"overallStatus":74,"whyStopped":34,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":34},{"fullName":5,"class":6},"Stanford University","OTHER",[8,14,19,24],{"label":9,"type":10,"description":11,"interventionNames":12},"4hr NPO","ACTIVE_COMPARATOR","Miralax will be stopped 4 hours prior anesthesia induction",[13],"Behavioral: Stopping Miralax ingestion 4 hours prior to anesthesia induction",{"label":15,"type":10,"description":16,"interventionNames":17},"3hr NPO","Miralax will be stopped 3 hours prior anesthesia induction",[18],"Behavioral: Stopping Miralax ingestion 3 hours prior to anesthesia induction",{"label":20,"type":10,"description":21,"interventionNames":22},"2hr NPO","Miralax will be stopped 2 hours prior anesthesia induction",[23],"Behavioral: Stopping Miralax ingestion 2 hours prior to anesthesia induction",{"label":25,"type":10,"description":26,"interventionNames":27},"1hr NPO","Miralax will be stopped 1 hour prior anesthesia induction",[28],"Behavioral: Stopping Miralax ingestion 1 hour prior to anesthesia induction",[30,35,38,41],{"type":31,"name":32,"description":32,"armGroupLabels":33,"otherNames":34},"BEHAVIORAL","Stopping Miralax ingestion 4 hours prior to anesthesia induction",[9],null,{"type":31,"name":36,"description":36,"armGroupLabels":37,"otherNames":34},"Stopping Miralax ingestion 3 hours prior to anesthesia induction",[15],{"type":31,"name":39,"description":39,"armGroupLabels":40,"otherNames":34},"Stopping Miralax ingestion 2 hours prior to anesthesia induction",[20],{"type":31,"name":42,"description":42,"armGroupLabels":43,"otherNames":34},"Stopping Miralax ingestion 1 hour prior to anesthesia induction",[25],{"type":45,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":34,"oldOrganization":34},"PRINCIPAL_INVESTIGATOR","Stephanie Jiaying Pan","Clinical Associate Professor","100637351","effect-of-miralax-npo-time-on-residual-gastric-volumes-and-bowel-preparation-100637351",false,"NCT07616908","Effect of Miralax NPO Time on Residual Gastric Volumes and Bowel Preparation","Inclusion Criteria:\n\n* Patients undergoing both EGD and colonoscopy\n* Use of Miralax for cleanout\n* Patients \\\u003C19 years old\n\nExclusion Criteria:\n\n* Patients with a history of delayed gastric emptying (eg diabetic, GLP-1 intake)\n* Patients with a history of gastric sleeve surgery\n* Use of Golytely for cleanout\n* Emergent EGD\u002Fcolonoscopies\n* EGD\u002Fcolonoscopies for foreign body removal and\u002For decompression\n* Known neurologic compromise\n* Presence of pre-existing ostomy, short bowel syndrome, gastric retention, intestinal obstruction, ileus, bowel perforation, toxic colitis, toxic megacolon, swallowing difficulties\n* Pre-existing electrolyte derangements\n* Allergy to Miralax","ALL","18 Years",{"count":57,"type":58},200,"ESTIMATED","INTERVENTIONAL",[61],"NA","The goal of this clinical trial is to assess differences in residual gastric volumes after stopping Miralax ingestion at different time points (1-4 hours) prior to anesthesia induction.",[64,65],"Residual Gastric Contents","Polyethylene Glycol",[67,68,69,70,71,72,73],"residual gastric volume","miralax","polythylene glycol","gastric POCUS","pediatric","EGD","colonoscopy","NOT_YET_RECRUITING","2026-05-26",{"date":77,"type":78},"2026-06-01","ACTUAL",{"date":80,"type":58},"2026-07",{"date":82,"type":58},"2028-06",{"name":5,"class":6}]